The global animal blood plasma products and derivatives market
features a fairly fragmented landscape with the presence of a large
number of players. However, intense competition exists between a few
large players. The combined share of leading companies such as
Proliant, Thermo Fisher Scientific, and Sigma-Aldrich collectively,
exceeded 76.0% of the market in 2016, with Proliant holding the
dominant share, notes Transparency Market Research (TMR). Several
vendors are actively consolidating their distribution networks across
various regions by forming strategic partnerships with a number of
indigenous distributors, raw materials suppliers, and manufacturers.
Numerous companies based in developed nations are expected to expand
their presence in emerging markets by opting for mergers,
acquisitions, and partnerships, in order to strengthen their
presence, observes TMR.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21455
The global market for animal blood plasma products and derivatives
was valued at US$1.04 bn in 2015. Rising at a CAGR of 7.10% during
2016–2024, the opportunities in the market is anticipated to reach
US$1.92 bn by the end of 2024.
Numerous Applications of Blood Plasma in Food Industry Reflect
Positively on Market
Geographically, North America occupied the major market share in 2015
and is expected to retain its lead throughout the forecast period.
The growth of this regional market is driven by the presence of
several prominent players who are constantly offering innovative
products for varied cell culture applications by actively focusing on
a diversified portfolio of cell lines.
The major applications areas of animal blood plasma products and
derivatives are cell culture media, nutrition supplements, sports
nutrition, the pharmaceutical industry, the food industry, the
cosmetic industry, the pet food industry, and the diagnostics
industry. Of these, the food industry is projected to grow at a
substantial pace over the forecast period. The growth of this segment
is attributed to the wide applications of plasma in making food
products in various developed markets.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=21455
Constant Advancements in Blood Collection and Processing
Techniques Boost Market
The developments in the global animal blood plasma products and
derivatives market is primarily driven by applications of animal
blood plasma in the food industry, especially for making pet food.
The utilization of blood plasma and derivatives in the food industry
is largely motivated by scores of nutritional benefits, along with
economic and environmental ones. The burgeoning demand for premium
quality and healthy solutions of blood plasma products in making a
variety of wet pet foods and pet snacks is a key factor boosting the
market. In addition, the growing application of blood plasma and
derivatives to increasingly substitute plant-extracted proteins for
making pet food bodes well for the market. Furthermore, constant
improvements in supply chain and distribution networks by various
players is expected to positively impact the animal blood plasma
products and derivatives market.
Recent advances in blood collection and processing techniques have
catalyzed the market. The availability of modern blood processing
technologies in North America is expected to fuel the market growth
in the coming years. For instance, substantial efforts have been
focused on augmenting the utility of the cellular fraction in food
proteins, which is expected to propel the market over the forecast
period. The increasing import of animals to advanced regions from
countries such as Australia and New Zealand is expected to accelerate
blood collection processes, thereby accentuating the market.
Request for the TOC of the Report @
https://www.transparencymarketresearch.com/report-toc/21455
However, marked price volatility in animal blood plasma products,
coupled with rising prevalence of diseases among animals, is a key
factor hindering the market growth to an extent. Nevertheless, recent
advancements in techniques for processing blood plasma and
derivatives are expected to open up exciting opportunities for market
players in major regions. Furthermore, the growing significance of
cell culture media in conventional research and for the development
of vital biomolecules and therapeutics is expected to open up
lucrative growth avenues for players to capitalize on in the
forthcoming years.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment